New lung cancer drug can help extend lives 14 percent

June 1, 2014 6:41 AM

8 0

New lung cancer drug can help extend lives 14 percent

Ramucirumab, a drug that was made to help patients with gastric cancer, is now going to be used to help patients with lung cancer who have previously experienced a relapse after chemotherapy.

The Cancer Research Center of Lyon in France conducted a study that involved 1,253 patients with non-small cell lung cancer. Each patient had previously undergone chemotherapy treatments yet experienced a relapse. Patients then received either the chemotherapy drug docetaxel with ramucirumab or a pl...

Also read: Synergy Pharma's irritable bowel drug succeeds in key study

Read more

To category page

Loading...